Phase Ⅰ Study of Icotinib hydrochloride with Intensity-Modulated Radiotherapy in Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma Icotinib hydrochloride Intensity-modulated radiotherapy Dose-limiting toxicity
Haihua Yang Wei Hu Peinong Yang Wei Wang Chao Zhou Weifang Yang Xiaofeng Chen
Department of Radiation Oncology,, Taizhou Hospital, Wenzhou Medical University, Wenzhou, 317000, Zh Department of Pathology,Taizhou Hospital, Wenzhou Medical University, Wenzhou, 317000, Zhejiang, Chi Medical Research Center, Taizhou Hospital, Wenzhou Medical University, Wenzhou, 317000, Zhejiang, Ch
国内会议
杭州
英文
57-58
2014-05-16(万方平台首次上网日期,不代表论文的发表时间)